WASHINGTON, Feb 2 (Reuters) - Human Genome Sciences Inc. said on Monday it was beginning delivery of 20,000 doses of ABthrax, which fights anthrax infection, to the U.S. government.
WASHINGTON, Feb 2 (Reuters) - Human Genome Sciences Inc. said on Monday it was beginning delivery of 20,000 doses of ABthrax, which fights anthrax infection, to the U.S. government.
